Gastric cancer: Nanoparticles as tools to improve treatment efficacy
Author
dc.contributor.author
Guerrero, Ariel R.
Author
dc.contributor.author
Oyarzún Ampuero, Felipe
Author
dc.contributor.author
Hassan, Natalia
Author
dc.contributor.author
Corvalán, Alejandro
Author
dc.contributor.author
Quest, Andrew F. G.
Author
dc.contributor.author
Kogan Bocian, Marcelo
Admission date
dc.date.accessioned
2018-12-20T15:13:18Z
Available date
dc.date.available
2018-12-20T15:13:18Z
Publication date
dc.date.issued
2016
Cita de ítem
dc.identifier.citation
Current Pharmaceutical Design, Volumen 22, Issue 39, 2018, Pages 5988-5997
Identifier
dc.identifier.issn
18734286
Identifier
dc.identifier.issn
13816128
Identifier
dc.identifier.other
10.2174/1381612822666160712165409
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/158578
Abstract
dc.description.abstract
In recent years, advances in nanotechnology have raised the specter of developing effective agents for the treatment of high-impact diseases, like gastric cancer, which remains one of the major causes of cancer deaths worldwide. This article reviews advances in the treatment of this pathology using several types of nanoparticles. First, we start with an overview of gastric cancer, its prevention, detection and the available treatments. Then, we discuss nanotechnology-based novel strategies using polymeric nanosystems, nanovesicular systems and inorganic nanoparticles. All of these systems are being evaluated in the perspective of improving the targeting of anticancer drugs and reducing their negative side effects.